This image shows a close-up of medical packaging with highlighted warning text, including instructions for pregnant or breastfeeding users and child safety. It visually supports the article’s message about the dangers of non-readable or poor-quality printing in pharmaceutical labelling. Small fonts, unclear layout, or low contrast can make essential information difficult to read, especially for vulnerable patients. Ensuring legibility is not only a regulatory requirement (per MHRA, EMA, and WHO guidance) but a vital part of patient safety and brand protection.